Thrombolysis in myocardial infarction (TIMI) trial, phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge

Circulation

Volumn 76, Issue 1, 1987, Pages 142-154

  Chesebro, J H ^a   Knatterud, G ^a   Roberts, R ^a   Borer, J ^b   Cohen, L S ^b   Dalen, J ^b   Dodge, H T ^b   Francis, C K ^b   Hillis, D ^b   Ludbrook, P ^b  

^a MARYLAND MEDICAL RESEARCH INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

FIBRIN DEGRADATION PRODUCT; FIBRINOGEN; GLYCERYL TRINITRATE; HEPARIN; PLASMINOGEN; STREPTOKINASE; TISSUE PLASMINOGEN ACTIVATOR;

ANGIOCARDIOGRAPHY; BLOOD AND HEMOPOIETIC SYSTEM; BLOOD CLOT LYSIS; CARDIOVASCULAR SYSTEM; CONTROLLED STUDY; DIAGNOSIS; DRUG COMPARISON; DRUG EFFICACY; DRUG INDICATION; DRUG THERAPY; HEART; HEART INFARCTION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; THERAPY;

EID: 0023258694     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.76.1.142     Document Type: Article

References (0)